APR 14, 2021 10:47 PM PDT

Anti-Aging Compound Improves Glucose Uptake

WRITTEN BY: Nouran Amin

According to new research at Washington University School of Medicine in St. Louis, a substance shown to counteract aspects of aging in healthy mice was proven to increase glucose uptake in humans in a small clinical trial.

Learn more about glucose uptake:

These clinical studies looked into postmenopausal women with prediabetes who were treated with NMN (nicotinamide mononucleotide). The NMN treatment improved the ability of insulin to increase glucose uptake in skeletal muscle that is often impaired in people with obesity, prediabetes or Type 2 diabetes. Findings were reported in the journal Science and was the first to discuss the metabolic effects of NMN administration in humans.

"Although our study shows a beneficial effect of NMN in skeletal muscle, it is premature to make any clinical recommendations based on the results from our study," said senior investigator Samuel Klein, MD, the William H. Danforth Professor of Medicine and Nutritional Science and director of the Center for Human Nutrition. "Normally, when a treatment improves insulin sensitivity in skeletal muscle, as is observed with weight loss or some diabetes medications, there also are related improvements in other markers of metabolic health, which we did not detect in our study participants."

Source: Science Daily

About the Author
Master's (MA/MS/Other)
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
DEC 04, 2022
Cannabis Sciences
Increasing Interest in Psychoactive Treatments for Mood Disorders
Increasing Interest in Psychoactive Treatments for Mood Disorders
Findings from various studies presented at the Society for Neuroscience 2022 annual meeting highlighted the need for inn ...
DEC 11, 2022
Drug Discovery & Development
Novel Dermatitis Treatment Produces Long-Term Results in Clinical Trials
Novel Dermatitis Treatment Produces Long-Term Results in Clinical Trials
A monoclonal antibody drug known as rocatinlimab produced significant results in patients with moderate to severe atopic ...
DEC 14, 2022
Drug Discovery & Development
The Two Brains Exposed by Ketamine
The Two Brains Exposed by Ketamine
Researchers out of the University of Pennsylvania have discovered our brains are split in two and not just along the hem ...
DEC 14, 2022
Cannabis Sciences
Cannabis Media Coverage Generally Positive Regardless of Clinical Outcome
Cannabis Media Coverage Generally Positive Regardless of Clinical Outcome
A study published in JAMA Open Network shows that cannabis receives significant media coverage regardless of the clinica ...
DEC 21, 2022
Neuroscience
Could gut bacteria affect social behavior?
Could gut bacteria affect social behavior?
Social behavior is common to all animal species and refers to interactions between individuals of a species. Studying so ...
JAN 19, 2023
Drug Discovery & Development
Introducing TruCytes™: The Ready-to-Use Immunophenotyping Control for Cell Therapy, Flow Cytometry and Beyond
Introducing TruCytes™: The Ready-to-Use Immunophenotyping Control for Cell Therapy, Flow Cytometry and Beyond
Are you a cell biologist, immunologist, or flow cytometrist? If so, you know how challenging it is to find quality contr ...
Loading Comments...